Biocon unit gets USFDA nod for genetic anti-bacterial drug

Biocon unit gets USFDA nod for genetic anti-bacterial drug

Biocon on Tuesday said its unit in partnership with Carnegie Pharmaceuticals LLC has received approval from the US health regulator for a genetic anti-bacterial medication. Biocon Pharma, a wholly-owned subsidiary of the company, in partnership with Carnegie, has received tentative approval from the US Food and Drug Administration (USFDA) for the ANDA for Rifaximin Tablets,…

Read More
Just like bad medicine…Trump tariff pricks again; India not seen badly hit by US’ latest salvo

Just like bad medicine…Trump tariff pricks again; India not seen badly hit by US’ latest salvo

US President Donald Trump’s Friday announcement of a 100% tariff on pharmaceutical products may not affect Indian pharma exports as the measure currently targets only “patented and branded products,” while India predominantly ships generic drugs to the US, experts said. “Because the 100% tariff is targeted at branded/patented drugs, most Indian generic exports would not…

Read More
Weight-loss drug Ozempic to debut in India soon

Weight-loss drug Ozempic to debut in India soon

Danish drug maker Novo Nordisk is set to launch in India Ozempic (semaglutide), its trailblazing once-a-week injectable brand that was originally approved to manage type 2 diabetes but found unprecedented demand for its significant benefits in patients with obesity or weight management issues. Approved first by the US FDA in 2017, Ozempic saw its global…

Read More